Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. GOOGL
2. TSLA
3. AMD
4. INTC
5. TXN
6. NOW
7. GOOG
8. CSX
9. ACI
10. IBM

Go back to Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older
Alabama Power Co. 5.875% Sr. Notes Series 2007B (NASDAQ: ALM) Delayed: 14.18 --0 (-0%)
Previous Close $14.18    52 Week High $27.10 
Open $14.18    52 Week Low $24.10 
Day High $14.18    P/E N/A 
Day Low $14.18    EPS $0.00 
Volume 6,245       

Alabama Power Co. 5.875% Sr. Notes Series 2007B (NASDAQ: ALM) Delayed: 14.18 --0 (-0%)
Previous Close $14.18    52 Week High $27.10 
Open $14.18    52 Week Low $24.10 
Day High $14.18    P/E N/A 
Day Low $14.18    EPS $0.00 
Volume 6,245